Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp ADR (NQ: AMRN )

1.600 +0.030 (+1.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,387,400
Open 1.610
Bid (Size) 1.580 (110)
Ask (Size) 1.640 (10)
Prev. Close 1.570
Today's Range 1.571 - 1.660
52wk Range 1.040 - 3.740
Shares Outstanding 404,346,256
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Reconstituted Amarin Board Ready for the Challenge of Unlocking True Potential of VASCEPA®/VAZKEPA® (Icosapent Ethyl)
From Amarin Corporation plc
Via Globe NewsWire
Amarin Announces Board Departures
From Amarin Corporation plc
Via Globe NewsWire

Performance

YTD
+34.45%
+34.45%
1 Month
-11.11%
-11.11%
3 Month
+28.00%
+28.00%
6 Month
+39.13%
+39.13%
1 Year
-47.88%
-47.88%

More News

Read More
Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients Presented at ACC.23/WCC
From Amarin Corporation plc
Via Globe NewsWire
Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome
Via Benzinga
Amarin Plc (AMRN) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Earnings Scheduled For March 1, 2023
Via Benzinga
Amarin Announces New REDUCE-IT® Data at ACC.23/WCC Showing Benefit of VASCEPA®/VAZKEPA® (Icosapent Ethyl) in High-Risk Patients with a Recent Acute Coronary Syndrome Event
From Amarin Corporation plc
Via Globe NewsWire
Amarin Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Wins Proxy Contest Against Amarin by Huge Landslide
From Sarissa Capital Management LP
Via Business Wire
Amarin Announces Preliminary Voting Results Following 2023 General Meeting of Shareholders
From Amarin Corporation plc
Via Globe NewsWire
Amarin and CSL Seqirus Announce Exclusive License and Distribution Agreement to Commercialize VAZKEPA® (Icosapent Ethyl) in Australia and New Zealand
From Amarin Corporation plc
Via Globe NewsWire
Amarin Sets the Record Straight on Sarissa’s Latest Misstatements
From Amarin Corporation plc
Via Globe NewsWire
Amarin Corporation to Present New Data Evaluating VASCEPA®/VAZKEPA® (Icosapent Ethyl) at ACC.23/WCC
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Condemns Amarin Board for Frontrunning Results of Proxy Contest With Egregious Equity Grants to Executives
From Sarissa Capital Management LP
Via Business Wire
Amarin to Present at Cowen's 43rd Annual Health Care Conference
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Reminds Amarin Shareholders Today Is the Last Day to Vote “FOR” Change
From Sarissa Capital Management LP
Via Business Wire
Amarin to Report Fourth Quarter and Full Year 2022 Financial Results And Host Conference Call on March 1st, 2023
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Urges Amarin Shareholders to Vote “FOR” Necessary Change
From Sarissa Capital Management LP
Via Business Wire
Amarin Urges Shareholders to Vote “Against” Sarissa’s Harmful Proposals at Upcoming General Meeting – IT HAS NO PLAN, NO NEW IDEAS AND AN UNDERQUALIFIED SLATE
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Urges Amarin Shareholders to Vote for Change and Remake Amarin for Shareholders
From Sarissa Capital Management LP
Via Business Wire
Sarissa Capital Blasts Amarin’s Repeated False Statements; Clearly Amarin Will Say Anything to Keep Sarissa Off the Board
From Sarissa Capital Management LP
Via Business Wire
Leading Independent Proxy Firm ISS Joins Glass Lewis in Recommending that Amarin Shareholders Vote “AGAINST” Sarissa’s Value-Destructive Proposals
From Amarin Corporation plc
Via Globe NewsWire
Amarin Clearly and Definitively Instructed Registrar to Accept ALL Submitted Proxy Cards
From Amarin Corporation plc
Via Globe NewsWire
Sarissa Capital Uncovers That Amarin’s Registrar Had Not Been Instructed to Accept Blue Proxy Cards Even Though Legally Required to Do So
From Sarissa Capital Management LP
Via Business Wire
Sarissa Capital Disappointed That Amarin Webcast Continues Board’s Defense of Poor Results and Lack of Accountability
From Sarissa Capital Management LP
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.